ChromaDex (NASDAQ: CDXC) reported Q4 EPS of $0.09, $0.07 better than the analyst estimate of $0.02. Revenue for the quarter came in at $29.1 million versus the consensus estimate of $26.78 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.